These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 21244342)

  • 1. Safety evaluation of colesevelam therapy to achieve glycemic and lipid goals in type 2 diabetes.
    Avitabile N; Banka A; Fonseca VA
    Expert Opin Drug Saf; 2011 Mar; 10(2):305-10. PubMed ID: 21244342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of colesevelam hydrochloride in hypercholesterolemia and type 2 diabetes mellitus.
    Brunetti L; Hermes-Desantis ER
    Ann Pharmacother; 2010; 44(7-8):1196-206. PubMed ID: 20551301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical efficacy of colesevelam in type 2 diabetes mellitus.
    Brunetti L; Campbell RK
    J Pharm Pract; 2011 Aug; 24(4):417-25. PubMed ID: 21813819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colesevelam added to combination therapy with a statin and ezetimibe in patients with familial hypercholesterolemia: a 12-week, multicenter, randomized, double-blind, controlled trial.
    Huijgen R; Abbink EJ; Bruckert E; Stalenhoef AF; Imholz BP; Durrington PN; Trip MD; Eriksson M; Visseren FL; Schaefer JR; Kastelein JJ;
    Clin Ther; 2010 Apr; 32(4):615-25. PubMed ID: 20435231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The efficacy of colesevelam HCl in the treatment of heterozygous familial hypercholesterolemia in pediatric and adult patients.
    Davidson M
    Clin Ther; 2013 Aug; 35(8):1247-52. PubMed ID: 23916045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of colesevelam in patients with type 2 diabetes mellitus and inadequate glycemic control receiving insulin-based therapy.
    Goldberg RB; Fonseca VA; Truitt KE; Jones MR
    Arch Intern Med; 2008 Jul; 168(14):1531-40. PubMed ID: 18663165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expanded colesevelam administration options with oral suspension formulation for patients with diabetes and hypercholesterolemia.
    Dayer-Berenson L; Finckenor M
    Postgrad Med; 2014 May; 126(3):126-34. PubMed ID: 24918798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What role for [black triangle down] colesevelam in cardiovascular prevention?
    Drug Ther Bull; 2009 May; 47(5):53-5. PubMed ID: 19423677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of colesevelam hydrochloride on low-density lipoprotein cholesterol and high-sensitivity C-reactive protein when added to statins in patients with hypercholesterolemia.
    Bays HE; Davidson M; Jones MR; Abby SL
    Am J Cardiol; 2006 Apr; 97(8):1198-205. PubMed ID: 16616026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colesevelam: a new and improved bile acid sequestrant?
    Tziomalos K; Karagiannis A; Mikhailidis DP; Athyros VG
    Curr Pharm Des; 2013; 19(17):3115-23. PubMed ID: 23317402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colesevelam hydrochloride: a novel bile acid-binding resin.
    Aldridge MA; Ito MK
    Ann Pharmacother; 2001; 35(7-8):898-907. PubMed ID: 11485143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Initial combination therapy with metformin and colesevelam for achievement of glycemic and lipid goals in early type 2 diabetes.
    Rosenstock J; Fonseca VA; Garvey WT; Goldberg RB; Handelsman Y; Abby SL; Lai YL; Jin X; Misir S; Nagendran S; Jones MR
    Endocr Pract; 2010; 16(4):629-40. PubMed ID: 20634175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colesevelam: in pediatric patients with heterozygous familial hypercholesterolemia.
    Perry CM
    Paediatr Drugs; 2010 Apr; 12(2):133-40. PubMed ID: 20218749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficacy of colesevelam HCl in the treatment of elderly patients.
    Gavin JR; Jones MR; Ford DM; Truitt KE
    Drugs Aging; 2014 Jun; 31(6):461-70. PubMed ID: 24777691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colesevelam hydrochloride: usefulness of a specifically engineered bile acid sequestrant for lowering LDL-cholesterol.
    Corsini A; Windler E; Farnier M
    Eur J Cardiovasc Prev Rehabil; 2009 Feb; 16(1):1-9. PubMed ID: 19237992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rationale and design of a clinical trial to evaluate metformin and colesevelam HCl as first-line therapy in type 2 diabetes and colesevelam HCl in prediabetes.
    Jones MR; Mudaliar S; Hernandez-Triana E; Unnikrishnan AG; Lai YL; Abby SL; Misir S; Jin X; Nagendran S
    Curr Med Res Opin; 2009 Sep; 25(9):2239-49. PubMed ID: 19622007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of colesevelam hydrochloride for the treatment of type 2 diabetes.
    Younk LM; Davis SN
    Expert Opin Drug Metab Toxicol; 2012 Apr; 8(4):515-25. PubMed ID: 22432790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review of studies on the effect of bile acid sequestrants in patients with type 2 diabetes mellitus.
    Levy P
    Metab Syndr Relat Disord; 2010 Dec; 8 Suppl 1():S9-13. PubMed ID: 20946010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colesevelam: a review of its use in hypercholesterolemia.
    Robinson DM; Keating GM
    Am J Cardiovasc Drugs; 2007; 7(6):453-65. PubMed ID: 18076213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term Safety and Tolerability of Colesevelam HCl in Subjects with Type 2 Diabetes.
    Goldfine AB; Fonseca VA; Jones MR; Wang AC; Ford DM; Truitt KE
    Horm Metab Res; 2010 Jan; 42(1):23-30. PubMed ID: 19862667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.